Development of potential CDK9 inhibitors through pharmacophore-based virtual screening, 3D-QSAR, molecular docking, MD simulation, and in vitro anticancer evaluation

Related articles

1. Machine Learning–Guided QSAR Screening of Fluconazole Analogs and FDA-Approved Drugs against Candida albicans, with Docking, Molecular Dynamics, and ADMET Analysis

   This article has 5 authors:

   1. Hamza Age Daudo
   2. Emmanuel Silva Marinho
   3. Victor Moreira de Oliveira
   4. Márcia Machado Marinho
   5. Ribeiro Vasco Ribeiro

2. ZINCPharmer-Based Identification of Multi-Target Inhibitors for Erectile Dysfunction: Pharmacophore Virtual Screening and Molecular Docking of Commercially Available Compounds

   This article has 2 authors:

   1. Ibrahim Adeola Moronfolu
   2. Abiodun Musliudeen Ibrahim

3. Chimeric 3D Model of EGFR and VEGFR-2 for the Discovery of Dual Inhibitors

   This article has 5 authors:

   1. Harold H. Fokoue
   2. Lucas S. Franco
   3. Rodolfo C. Maia
   4. Eliezer J. Barreiro
   5. Carlos M. R. Sant’Anna